Syngene Intl. vs Fortis Health.
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Fortis Health. currently has the stronger revenue growth signal.
Syngene Intl. and Fortis Health. show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Syngene Intl. | Fortis Health. |
|---|---|---|
| Current Price | ₹401 | ₹918 |
| Market Cap | ₹16,439.43 Cr. | ₹68,482.25 Cr. |
| Industry | Healthcare Services | Healthcare Services |
| P/E Ratio | 55.51 | 64.19 |
| ROE (%) | 7.78 | 11.23 |
| Debt/Equity | 0.09 | 0.35 |
| Sales Growth 5Y (%) | 11.35 | 17.76 |
| Profit Growth 5Y (%) | -6.83 | -1.35 |
| Promoter Holding (%) | 52.59 | 31.17 |
| Revenue Rank | Rank 4 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |